TRIM7 anticorps (FITC)

N° du produit ABIN1401206

Détail du produit anti-TRIM7 anticorps (FITC)

Antigène: TRIM7 (Tripartite Motif Containing 7 (TRIM7))

Reactivité: Humain, Rat, Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp TRIM7 est conjugé à/à la FITC

Application: Western Blotting (WB), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Réactivité croisée: Humain, Souris, Rat

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human TRIM7

Isotype: IgG

Information d'application

Indications d'application: IF(IHC-P) 1:50-200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Date de péremption: 12 months

Détails sur TRIM7

Antigène: TRIM7 (Tripartite Motif Containing 7 (TRIM7))

Autre désignation: TRIM7 (TRIM7 Produits)

Synonymes: anticorps GNIP, anticorps RNF90, anticorps AI790312, anticorps tripartite motif containing 7, anticorps tripartite motif-containing 7, anticorps TRIM7, anticorps Trim7

Sujet:

Synonyms: Glycogenin-interacting protein, GNIP, RING finger protein 90, RNF90, TRIM7, TRIM7_HUMAN, Tripartite Mot Containing 7, Tripartite mot protein TRIM 7, Tripartite mot-containing protein 7.

Background: The tripartite motif (TRIM) family of proteins are characterized by a conserved TRIM domain that includes a coiled-coil region, a B-box type zinc finger, one RING finger and three zinc-binding domains. TRIM7 (tripartite motif-containing 7), also known as RNF90 or GNIP, is a 511 amino acid protein that belongs to the TRIM family and contains one RING-type zinc finger, one B box-type zinc finger and one SPRY domain. Expressed in placenta and skeletal muscle and present at lower levels in brain, heart and pancreas, TRIM7 localizes to both the cytoplasm and the nucleus where it exists as dimers and is thought to participate in the initiation of glycogen synthesis. Multiple isoforms of TRIM7 exist due to alternative splicing events.

ID gène: 81786